Olfr1018 is an olfactory receptor. Currently, there are no specific chemical inhibitors that have been developed or identified for olfactory receptors like Olfr1018. Olfactory receptors are part of the G protein-coupled receptor (GPCR) family. GPCR inhibitors encompass a wide range of chemicals that modulate the activity of G protein-coupled receptors, a large and diverse group of membrane receptors involved in various physiological processes. These receptors play key roles in the sensory system, including olfaction, as well as in neurotransmission, cardiovascular regulation, immune system modulation, and more. The inhibition or modulation of GPCRs can be achieved through various mechanisms. Some inhibitors act as antagonists, binding to the receptor and preventing its activation by endogenous ligands. Others work as inverse agonists, reducing the receptor's basal activity. Additionally, allosteric modulators can modulate receptor activity by binding to sites other than the ligand-binding site, influencing the receptor's response to its ligand.
The complexity of GPCR signaling is due to their ability to activate multiple downstream pathways. This includes the activation of various G proteins (Gs, Gi/o, Gq/11) and beta-arrestin pathways, leading to the modulation of second messengers like cAMP, calcium ions, and inositol phosphates. The chemicals listed above represent a spectrum of GPCR modulation strategies. They include antagonists for adrenergic, serotonergic, dopaminergic, histaminergic, and other receptors. Each of these chemicals has a unique interaction with GPCRs, reflecting the diversity of this receptor family. Their effects on GPCR signaling can have downstream impacts on a variety of physiological processes, potentially including the modulation of olfactory receptor activity, although such effects would be indirect and not specific to Olfr1018. The specific application of these compounds to modulate Olfr1018 or related olfactory receptors remains an area of ongoing research.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A non-selective beta-adrenergic receptor antagonist that can indirectly influence GPCR signaling. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $80.00 $326.00 | 1 | |
A serotonin 5-HT3 receptor antagonist, potentially affecting GPCR-mediated signal transduction. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $127.00 | 18 | |
An angiotensin II receptor antagonist, modulating GPCR activity in cardiovascular systems. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
An atypical antipsychotic acting on various GPCRs, including dopaminergic and serotonergic receptors. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $50.00 $168.00 $520.00 | 2 | |
An alpha-2 adrenergic receptor antagonist, influencing adrenergic GPCR pathways. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
A non-selective beta-adrenergic antagonist with alpha-1 blocking activity, affecting GPCR signaling. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
A histamine H2 receptor antagonist, modulating GPCR activity in gastric acid secretion. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
A selective beta1-adrenergic receptor antagonist, indirectly influencing GPCR signaling pathways. | ||||||
Ramipril | 87333-19-5 | sc-205833 sc-205833A sc-205833B sc-205833C sc-205833D | 500 mg 1 g 2 g 5 g 10 g | $175.00 $240.00 $357.00 $719.00 $1229.00 | 1 | |
An ACE inhibitor, indirectly affecting GPCR-mediated angiotensin II activity. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
A dopamine receptor antagonist, influencing dopaminergic GPCR systems. | ||||||